183 related articles for article (PubMed ID: 20477822)
1. Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer.
Abe M; Xie W; Regan MM; King IB; Stampfer MJ; Kantoff PW; Oh WK; Chan JM
BJU Int; 2011 Jan; 107(1):126-34. PubMed ID: 20477822
[TBL] [Abstract][Full Text] [Related]
2. Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer.
Chan JM; Oh WK; Xie W; Regan MM; Stampfer MJ; King IB; Abe M; Kantoff PW
J Clin Oncol; 2009 Aug; 27(22):3577-83. PubMed ID: 19528373
[TBL] [Abstract][Full Text] [Related]
3. Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk.
Cooper ML; Adami HO; Grönberg H; Wiklund F; Green FR; Rayman MP
Cancer Res; 2008 Dec; 68(24):10171-7. PubMed ID: 19074884
[TBL] [Abstract][Full Text] [Related]
4. Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer.
Nordström T; Van Blarigan EL; Ngo V; Roy R; Weinberg V; Song X; Simko J; Carroll PR; Chan JM; Paris PL
Prostate; 2016 Mar; 76(4):339-48. PubMed ID: 26585352
[TBL] [Abstract][Full Text] [Related]
5. Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival.
Van Blarigan EL; Ma J; Kenfield SA; Stampfer MJ; Sesso HD; Giovannucci EL; Witte JS; Erdman JW; Chan JM; Penney KL
Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):1037-46. PubMed ID: 24711484
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence.
Bauer SR; Richman EL; Sosa E; Weinberg V; Song X; Witte JS; Carroll PR; Chan JM
Prostate; 2013 Dec; 73(16):1786-95. PubMed ID: 24038157
[TBL] [Abstract][Full Text] [Related]
7. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence.
Gerstenberger JP; Bauer SR; Van Blarigan EL; Sosa E; Song X; Witte JS; Carroll PR; Chan JM
Prostate; 2015 Jan; 75(1):60-9. PubMed ID: 25284284
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of Antioxidant Enzymes SOD2 (rs4880) and GPX1 (rs1050450) Are Associated with Bladder Cancer Risk or Its Aggressiveness.
Nikic P; Dragicevic D; Jerotic D; Savic S; Djukic T; Stankovic B; Kovacevic L; Simic T; Matic M
Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676755
[TBL] [Abstract][Full Text] [Related]
9. Concentration/activity of superoxide dismutase isozymes and the pro-/antioxidative status, in context of type 2 diabetes and selected single nucleotide polymorphisms (genes: INS, SOD1, SOD2, SOD3) - Preliminary findings.
Lewandowski Ł; Urbanowicz I; Kepinska M; Milnerowicz H
Biomed Pharmacother; 2021 May; 137():111396. PubMed ID: 33761612
[TBL] [Abstract][Full Text] [Related]
10. Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis.
Xie W; Yang M; Chan J; Sun T; Mucci LA; Penney KL; Lee GS; Kantoff PW
Prostate; 2016 May; 76(7):691-9. PubMed ID: 26847995
[TBL] [Abstract][Full Text] [Related]
11. A prospective study on associations between superoxide dismutase gene polymorphisms and antituberculosis drug-induced liver injury in a Chinese Han population.
Wu T; Bai H; Zhao Z; Wang M; Hu X; Jiao L; Wu Q; Liu T; Zhang C; Chen H; Zhang J; Song J; Wu L; Zhou W; Tong C; Ying B
J Gene Med; 2019 Oct; 21(10):e3121. PubMed ID: 31415712
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy.
Giesing M; Suchy B; Driesel G; Molitor D
BJU Int; 2010 Apr; 105(7):1000-10. PubMed ID: 19818074
[TBL] [Abstract][Full Text] [Related]
13. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer.
Li H; Kantoff PW; Giovannucci E; Leitzmann MF; Gaziano JM; Stampfer MJ; Ma J
Cancer Res; 2005 Mar; 65(6):2498-504. PubMed ID: 15781667
[TBL] [Abstract][Full Text] [Related]
14. Associations between SNPs within antioxidant genes and the risk of prostate cancer in the Siberian region of Russia.
Oskina NA; Еrmolenko NA; Boyarskih UA; Lazarev A; Petrova VD; Ganov DI; Tonacheva OG; Lifschitz GI; Filipenko ML
Pathol Oncol Res; 2014 Jul; 20(3):635-40. PubMed ID: 24610081
[TBL] [Abstract][Full Text] [Related]
15. The Association of Polymorphisms in Genes Encoding Antioxidant Enzymes GPX1 (rs1050450), SOD2 (rs4880) and Transcriptional Factor Nrf2 (rs6721961) with the Risk and Development of Prostate Cancer.
Djokic M; Radic T; Santric V; Dragicevic D; Suvakov S; Mihailovic S; Stankovic V; Cekerevac M; Simic T; Nikitovic M; Coric V
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295574
[No Abstract] [Full Text] [Related]
16. Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk.
Mikhak B; Hunter DJ; Spiegelman D; Platz EA; Wu K; Erdman JW; Giovannucci E
Carcinogenesis; 2008 Dec; 29(12):2335-40. PubMed ID: 18784358
[TBL] [Abstract][Full Text] [Related]
17. Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT.
Chan JM; Darke AK; Penney KL; Tangen CM; Goodman PJ; Lee GM; Sun T; Peisch S; Tinianow AM; Rae JM; Klein EA; Thompson IM; Kantoff PW; Mucci LA
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1050-1058. PubMed ID: 27197287
[TBL] [Abstract][Full Text] [Related]
18. Impact of oxidative stress SNPs and dietary antioxidant quality score on prostate cancer.
Pascual-Geler M; Robles-Fernandez I; Monteagudo C; Lopez-Guarnido O; Rodrigo L; Gálvez-Ontiveros Y; Cozar JM; Rivas A; Alvarez-Cubero MJ
Int J Food Sci Nutr; 2020 Jun; 71(4):500-508. PubMed ID: 31647334
[No Abstract] [Full Text] [Related]
19. Manganese superoxide dismutase (SOD2/MnSOD)/catalase and SOD2/GPx1 ratios as biomarkers for tumor progression and metastasis in prostate, colon, and lung cancer.
Miar A; Hevia D; Muñoz-Cimadevilla H; Astudillo A; Velasco J; Sainz RM; Mayo JC
Free Radic Biol Med; 2015 Aug; 85():45-55. PubMed ID: 25866291
[TBL] [Abstract][Full Text] [Related]
20. Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer.
Burri RJ; Stock RG; Cesaretti JA; Atencio DP; Peters S; Peters CA; Fan G; Stone NN; Ostrer H; Rosenstein BS
Radiat Res; 2008 Jul; 170(1):49-59. PubMed ID: 18582155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
